Immunovant Inc.

IMVT | NASDAQ

Price Alert Chart Builder DCF Calculator

$37.20

+$0.02 (+0.05%)

Sep 22, 2026, 11:04 AM ET · Market open

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

Income Statement Balance Sheet Cashflow Statement Ratios

Annual Quarterly TTM

Fiscal Year Period Ending	FY 2026 Mar 30, 2026	FY 2025 Mar 30, 2025	FY 2024 Mar 30, 2024	FY 2023 Mar 30, 2023	FY 2022 Mar 30, 2022	FY 2021 Mar 30, 2021
Cash & Equivalents	902.11M	713.97M	635.37M	376.53M	493.82M	400.15M
Short-Term Investments	n/a	n/a	n/a	n/a	n/a	n/a
Long-Term Investments	n/a	n/a	n/a	n/a	n/a	n/a
Other Long-Term Assets	7.68M	7.62M	n/a	n/a	n/a	n/a
Receivables	3.95M	2.51M	5.5M	885K	12.86M	1.14M
Inventory	n/a	n/a	n/a	n/a	n/a	n/a
Other Current Assets	42.76M	51.18M	24.9M	n/a	n/a	n/a
Total Current Assets	948.82M	767.66M	665.77M	404.33M	512.93M	409.01M
Property-Plant & Equipment	515K	942K	595K	1.51M	2.63M	3.48M
Goodwill & Intangibles	n/a	n/a	n/a	n/a	n/a	n/a
Total Long-Term Assets	8.75M	8.56M	942K	1.51M	2.63M	3.48M
Total Assets	957.57M	776.22M	666.71M	405.84M	515.56M	412.49M
Account Payables	7.54M	17.66M	7.16M	1.35M	18.63M	2.43M
Deferred Revenue	n/a	n/a	n/a	n/a	n/a	n/a
Short-Term Debt	n/a	n/a	n/a	n/a	n/a	n/a
Other Current Liabilities	16.77M	15.62M	14.74M	350K	171K	3.14M
Total Current Liabilities	104.42M	68.78M	48.61M	43.3M	44.52M	18.77M
Long-Term Debt	n/a	n/a	n/a	n/a	n/a	n/a
Other Long-Term Liabilities	n/a	n/a	n/a	n/a	n/a	n/a
Total Long-Term Liabilities	553K	n/a	347K	47K	1.22M	2.24M
Total Liabilities	104.98M	68.78M	48.96M	43.34M	45.74M	21.01M
Total Debt	72K	98K	138K	1.22M	2.36M	3.42M
Book Value	852.59M	707.45M	617.76M	362.49M	469.83M	391.48M
Book Value Per Share	4.67	4.67	4.47	2.95	4.28	4.46
Common Stock	20K	16K	14K	13K	12K	10K
Retained Earnings	-1.75B	-1.24B	-825.68M	-566.35M	-355.39M	-198.66M
Comprehensive Income	730K	1.46M	1.91M	852K	404K	-298K
Shareholders Equity	852.59M	707.45M	617.76M	362.49M	469.83M	391.48M
Total Investments	n/a	n/a	n/a	n/a	n/a	n/a